Apyx Medical Corporation (NASDAQ:APYX) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET

Company Participants

Charles Goodwin - President and Chief Executive Officer

Tara Semb - Chief Financial Officer

Conference Call Participants

Matt Hewitt - Craig-Hallum Capital Group

Matthew O’Brien - Piper Sandler

Kyle Bauser - Lake Street Capital Markets

Dave Turkaly - JMP Securities

Russell Cleveland - RENN Capital

Operator

Hello and welcome, ladies and gentlemen to Third Quarter of 2022 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in listen-only mode. At the end of the company’s prepared remarks, we will conduct a question-and-answer session. Please note that this conference call is being recorded and that the recording will be available on the company’s website for replay shortly.

Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including without limitation to those identified in the risk factors section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, our most recent 10-Q filing and the company’s other filings with the Securities and Exchange Commission. Such factors maybe updated from time-to-time in our filings with the SEC, which are available on our website.

We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise. This call will also include references to certain financial measures that are not calculated in accordance with Generally Accepted Accounting Principles, or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the Investor Relations portion of our website.

I would now like to turn the call over to Mr. Charlie Goodwin, Apyx Medical’s President and Chief Executive Officer. Please go ahead, sir.

Charles Goodwin

Thanks, operator. Welcome everyone to our third quarter earnings call. I am joined on today’s call by our Chief Financial Officer, Tara Semb.

Turning to a quick agenda of what we intend to cover today, I will start by reviewing our third quarter revenue results and the factors that contributed to our performance. Then I will provide you with an update of our operational progress during the third quarter and in recent months. Tara will then discuss our third quarter financial results in detail as well as our financial guidance for 2022, which we updated in today’s earnings release. I will conclude with some thoughts on our updated guidance and key areas of focus in the fourth quarter before we open the call for Q&A.